Title : Mucosal Epithelial Jak Kinases in Health and Diseases.

Pub. Date : 2021

PMID : 33814980






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A selective Jak3 inhibitor CP-690550 (Xeljanz) approved by the FDA for certain chronic inflammatory conditions demonstrates immunosuppressive activity in rheumatoid arthritis, psoriasis, and organ transplant rejection. tofacitinib Janus kinase 3 Mus musculus
2 A selective Jak3 inhibitor CP-690550 (Xeljanz) approved by the FDA for certain chronic inflammatory conditions demonstrates immunosuppressive activity in rheumatoid arthritis, psoriasis, and organ transplant rejection. tofacitinib Janus kinase 3 Mus musculus